James Brafford Email

SVP, Head Global Quality . DBV Technologies

Current Roles

Employees:
223
Revenue:
$1.6M
About
DBV Technologies is a clinical-stage biopharmaceutical company developing treatments to help those with food allergies. With a new class of self-administered and non-invasive product candidates, the company is dedicated to safely transforming the care of food allergic patients, for whom there are no approved treatments. DBV's food allergies programs include ongoing clinical trials of product candidates in Phase III, Phase II, and preclinical development. DBV is also pursuing a human proof-of-concept clinical study using their technology for the treatment of Eosinophilic Esophagitis, and exploring potential applications of its platform in vaccines and other immune diseases. Allergy, Food and pediatric allergy, Specific immunotherapy
DBV Technologies Address
12 East 49th Street
New York, NY
United States
DBV Technologies Email

Past Companies

DBV TechnologiesSenior Vice President, Head of Global Quality
Emergent BioSolutionsVice President, Head of Device Quality
AllerganExecutive Director, Global Quality Management Systems

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.